TREATMENT GUIDELINE FOR BIPOLAR MOOD DISORDER (BMD)
MANAGEMENT OF LEVEL 3
  LEVEL 1
GO TO ALGORITHM BMD MANAGEMENT LEVEL 2
  LEVEL 3
MANIA, MODERATE OR SEVERE DEPRESSION, RAPID CYCLING, FIRST EPISODE MANIA OR HYPOMANIA, CO-MORBIDITY ON AXIS 1, 2 OR 3, POOR RESPONSE TO TREATMENT. LEVEL 4
 
   
MANAGE AND TREAT CO-MORBIDITY  
   
NO DEFINITION FOR TREATMENT RESISTANCE  
   
POOR RESPONSE TO TREATMENT DEFINED AS RESPONSE BUT NO REMISSION  
   
ACUTE PHASE
 
   
  MEDICATION AND PSYCHOTHERAPY  
  MEDICATION FOR BIPOLAR MOOD DISORDER
 
INITIATE OR REFER FOR PSYCHOTHERAPY
EVIDENCE BASED PSYCHOTHERAPY FOR BMD
   
   
  EVIDENCE SUGGEST THAT THE COMBINATION OF MEDICATION AND PSYCHOTHERAPY SEEMS TO HAVE THE BEST OUTCOME AND IS THEREFOR ALWAYS RECOMMENDED IN ALL PATIENTS WHERE POSSIBLE  
   
   
  SUPPORTIVE PSYCHOTHERAPY UNTIL ABLE TO COMPREHEND  
  BEHAVIOUR THERAPY UNTIL ABLE TO COMPREHEND FULLY  
  EVIDENCE BASED PSYCHOTHERAPY FOR BMD  
 
ALWAYS IN COMBINATION WITH MEDICATION
 
   
  CONTINUE UNTIL PATIENT IS IN REMISSION REMISSION
   
  CBT OR PSYCHO-EDUCATION IF PATIENT IN FULL REMISSION  
   
  CONTINUE FOR AT LEAST 21 SESSIONS  
   
INITIATE MEDICATION
MEDICATION FOR BIPOLAR MOOD DISORDER
   
  MONITOR COMPLIANCE, ADHERENCE AND CONCORDANCE CONTINUOUSLY  
   
 
MANIA
 
   
   
  MANIA OR HYPOMANIA WITH EUPHORIC MOOD RAPID CYCLING MIXED OR DYSPHORIC MOOD MANIA WITH PSYCHOSIS
 
   
   
 
LITHIUM AND/OR VALPROATE AND/OR TYPICAL AND/OR SECOND GENERATION ANTI-PSYCHOTIC (IF IMI SGA GIVEN, NO BENZODIAZAPINE WITHIN 2 HOURS) ALWAYS COMBINATION IF SEVERE
VALPROATE AND/OR CARBAMAZEPINE/OXCARBAZEPINE  AND/OR LAMOTRIGINE AND/OR SECOND GENERATION ANTI-PSYCHOTIC (DISCONTINUE ANTI-DEPRESSANT) (IF IMI SGA GIVEN, NO BENZODIAZAPINE WITHIN 2 HOURS) VALPROATE AND/OR LITHIUM AND/OR CARBAMAZEPINE/OXCARBAZEPINE AND/OR SECOND GENERATION ANTI-PSYCHOTIC (IF IMI SGA GIVEN, NO BENZODIAZAPINE WITHIN 2 HOURS) TYPICAL OR ATYPICAL ANTI-PSYCHOTIC AND/OR LITHIUM AND/OR VALPROATE AND/OR CARBAMAZEPINE/OXCARBAZEPINE AND/OR BENZODIAZEPINE (LORAZEPAM/ CLONAZEPAM) (IF IMI SGA GIVEN, NO BENZODIAZAPINE WITHIN 2 HOURS)
 
 
 
 
 
 
 
 
 
 
 
   
   
   
 
CONTINUE FOR 4-6 WEEKS AND ASSESS
CONSIDER ECT AND GO TO LEVEL 4
  PRINCIPLES:
  COMBINATIONS OF MEDICATION IS THE NORM
 
  REMISSION MAINTENANCE PHASE
  GO THE FULL DOSE AS PER EVIDENCE AND PER BLOOD LEVEL AND TOLERATED DOSE  
 
 
  NO RESPONSE GO TO LEVEL 4
   
  CHECK COMPLIANCE, ADHERENCE AND CONCORDANCE
 
  RESPONSE BUT NO REMISSION CONSIDER ECT AND GO TO LEVEL 4
 
   
 
ADD ONE OF THE OTHER AGENTS
 
   
   
 
CONTINUE FOR 4-6 WEEKS AND ASSESS
 
   
 
 
  REMISSION MAINTENANCE PHASE
   
 
 
  RESPONSE BUT NO REMISSION CONSIDER ECT AND GO TO LEVEL 4
 
   
 
ADD A THIRD AGENT
 
   
 
 
  REMISSION MAINTENANCE PHASE
   
 
 
  RESPONSE BUT NO REMISSION CONSIDER ECT AND GO TO LEVEL 4
 
   
 
ADD A SGA OR LAMOTROGINE
 
   
   
 
CONTINUE FOR 4-6 WEEKS AND ASSESS
 
   
 
 
  REMISSION MAINTENANCE PHASE
   
 
 
  RESPONSE BUT NO REMISSION GO TO LEVEL 4
  RECONSIDER TREATMENT AND DIAGNOSIS
 
  ENSURE ADEQUATE PSYCHOTHERAPY
 
  RE-ASSESS AND USE DIFFERENT COMBINATIONS OF MEDICATION AND PSYCHOTHERAPY
 
 
 
 
   
 
CYCLOTHYMIA
 
   
   
 
LITHIUM AND/OR VALPROATE AND/OR LAMOTRIGINE
 
   
   
   
 
 
  CONTINUE FOR 4-6 WEEKS AND ASSESS REMISSION MAINTENANCE PHASE
   
   
  NO RESPONSE GO TO LEVEL 4
   
   
  RESPONSE BUT NO REMISSION  
   
   
  ADD ONE OF THE OTHER AGENTS  
   
   
 
CONTINUE FOR 4-6 WEEKS AND ASSESS
 
   
 
 
  REMISSION MAINTENANCE PHASE
   
 
 
  RESPONSE BUT NO REMISSION GO TO LEVEL 4
   
   
 
ADD A THIRD AGENT
 
   
   
 
CONTINUE FOR 4-6 WEEKS AND ASSESS
 
   
 
 
  REMISSION MAINTENANCE PHASE
   
 
 
  RESPONSE BUT NO REMISSION GO TO LEVEL 4
   
   
 
ADD A SGA OR LAMOTROGINE
 
   
   
 
CONTINUE FOR 4-6 WEEKS AND ASSESS
 
   
 
 
  REMISSION MAINTENANCE PHASE
   
 
 
  RESPONSE BUT NO REMISSION GO TO LEVEL 4
  RECONSIDER TREATMENT AND DIAGNOSIS
 
  ENSURE ADEQUATE PSYCHOTHERAPY
 
  RE-ASSESS AND USE DIFFERENT COMBINATIONS OF MEDICATION AND PSYCHOTHERAPY
 
 
 
 
   
 
MAJOR DEPRESSION
 
   
   
 
MILD OR MODERATE
SEVERE
WITH PSYCHOSIS
 
   
   
 
LAMOTRIGINE AND/OR LITHIUM AND/OR VALPROATE AND/OR ANTIDEPRESSANT AND/OR MOOD STABILIZER (DO NOT GIVE ANTI-DEPRESSANT WITHOUT MOOD STABILISER)
LAMOTRIGINE AND/OR LITHIUM AND/OR VALPROATE AND/OR ANTIDEPRESSANT AND/OR CARBAMAZEPINE/OXCARBAZEPINE   (DO NOT GIVE ANTI-DEPRESSANT WITHOUT MOOD STABILISER) IF SUICIDE RISK: CONSIDER ECT LAMOTRIGINE AND/OR LITHIUM AND/OR VALPROATE AND/OR WITH TYPICAL OR ATYPICAL ANTI-PSYCHOTIC AND/OR ANTIDEPRESSANT (DO NOT GIVE ANTI-DEPRESSANT WITHOUT MOOD STABILISER)  MAY CONSIDER ECT AS FIRST LINE TREATMENT  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
CONTINUE FOR 4-6 WEEKS AND ASSESS
CONSIDER ECT AND GO TO LEVEL 4
 
 
 
  REMISSION MAINTENANCE PHASE
   
 
 
  NO RESPONSE GO TO LEVEL 4
   
 
 
  RESPONSE BUT NO REMISSION CONSIDER ECT AND GO TO LEVEL 4
 
   
 
ADD ONE OF THE OTHER AGENTS
 
   
   
 
CONTINUE FOR 4-6 WEEKS AND ASSESS
 
   
 
 
  REMISSION MAINTENANCE PHASE
   
 
 
  RESPONSE BUT NO REMISSION CONSIDER ECT AND GO TO LEVEL 4
 
   
 
ADD A THIRD AGENT
 
   
 
 
  REMISSION MAINTENANCE PHASE
   
 
 
  RESPONSE BUT NO REMISSION CONSIDER ECT AND GO TO LEVEL 4
 
   
 
ADD A SGA OR LAMOTROGINE
 
   
   
 
CONTINUE FOR 4-6 WEEKS AND ASSESS
 
   
 
 
  REMISSION MAINTENANCE PHASE
   
 
 
  RESPONSE BUT NO REMISSION GO TO LEVEL 4
  RECONSIDER TREATMENT AND DIAGNOSIS
 
  ENSURE ADEQUATE PSYCHOTHERAPY
 
  RE-ASSESS AND USE DIFFERENT COMBINATIONS OF MEDICATION AND PSYCHOTHERAPY